NCT02615704 (eMocial) is a clinical trial of Active group with MEMS in Acute Coronary Syndrome, sponsored by AstraZeneca.

Who is sponsoring NCT02615704?

NCT02615704 is sponsored by AstraZeneca.

What drugs are being tested in NCT02615704?

Interventions in NCT02615704: Active group with MEMS, Active group without MEMS, Control group with MEMS, Control group without MEMS.

What condition does NCT02615704 study?

NCT02615704 studies Acute Coronary Syndrome.

Is NCT02615704 still recruiting?

NCT02615704 is currently completed. Last updated 4 June 2020.

Last reviewed 2020-06-04 · How we verify

NCT02615704: eMocial

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

"Me and My Heart" Study

Completed Last updated 4 June 2020

What this trial tests

trial testing Active group with MEMS in Acute Coronary Syndrome in 677 participants. Completed in 7 March 2019.

Timeline

11 February 2016

Primary endpoint
7 March 2019

7 March 2019

Quick facts

Lead sponsor	AstraZeneca
Status	Completed
Study type	OBSERVATIONAL
Enrollment	677
Start date	11 February 2016
Primary completion	7 March 2019
Estimated completion	7 March 2019
Sites	31 locations across Germany

Drugs / interventions tested

Active group with MEMS
Active group without MEMS
Control group with MEMS
Control group without MEMS

Conditions studied

Acute Coronary Syndrome — all drugs for Acute Coronary Syndrome →

Sponsor

AstraZeneca — full company profile →

Who can join

Adults 18 to 130, any sex, with Acute Coronary Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

An electronic device application (APP) "Mein Herz und ich" has been developed specifically for acute coronary syndrome (ACS) patients who are prescribed to Brilique (ticagrelor) to increase adherence to treatment (medication and lifestyle changes) by a combination of reminders on medication intake, information on the importance of treatment, motivation by supportive messages, and visualisation of individual lifestyle choices' effect on cardiovascular risk. The aim of this study is to evaluate the effectiveness of this patient support tool

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Results from the "Me & My Heart" (eMocial) Study: a Randomized Evaluation of a New Smartphone-Based Support Tool to Increase Therapy Adherence of Patients with Acute Coronary Syndrome.
Krackhardt F, Jörnten-Karlsson M, Waliszewski M, Knutsson M, et al · · 2023 · cited 5× · PMID 35441926 · DOI 10.1007/s10557-022-07331-1
Design and rationale for the "Me & My Heart" (eMocial) study: A randomized evaluation of a new smartphone-based support tool to increase therapy adherence of patients with acute coronary syndrome.
Krackhardt F, Maier LS, Appel KF, Köhler T, et al · · 2019 · cited 4× · PMID 31490566 · DOI 10.1002/clc.23254

Verify or expand the search:

Other recruiting trials for Acute Coronary Syndrome

Currently open trials in the same condition.

NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07230847 — A Study Evaluating the Vascular Healing and Neointimal Transformation at 1 Month After Implantation of BioFreedom™ Drug- · NA · recruiting
NCT07032389 — A Polypill for Acute Coronary Syndrome · Phase 2 · recruiting
NCT07102628 — Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronar · Phase 3 · recruiting
NCT06416813 — Preventive Intervention Value of DCB in Vulnerable Coronary Atherosclerotic Plaques · NA · active not recruiting

Other AstraZeneca trials

Trials by the same sponsor.

NCT06998095 — Tezepelumab (Tezspire) Regulatory Postmarketing Surveillance in Korea · not yet recruiting
NCT07431775 — Saphnelo Use in Females of Child-bearing Potential · not yet recruiting
NCT07516184 — Explore the Diagnostic Value of Bronchodilation Test With Portable Oscillometry in Asthma Diagnosis · NA · not yet recruiting
NCT07279935 — Osimertinib Combined With Chemotherapy in Patients Who Had Distant Recurrence After Adjuvant Osimertinib for EGFRm Resec · Phase 4 · not yet recruiting
NCT07279948 — A Single-arm Observational Study to Characterize the Demographic, Clinical Features and Outcomes of a Brazilian Cohort o · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02615704 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by AstraZeneca
Last refreshed: 4 June 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02615704.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing